These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8450430)

  • 1. Degradation and release properties of pellets fabricated from three commercial poly(D,L-lactide-co-glycolide) biodegradable polymers.
    Schmitt EA; Flanagan DR; Linhardt RJ
    J Pharm Sci; 1993 Mar; 82(3):326-9. PubMed ID: 8450430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D,L-lactide-co-glycolide) discs and polymer degradation.
    Kim JM; Seo KS; Jeong YK; Hai BL; Kim YS; Khang G
    J Biomater Sci Polym Ed; 2005; 16(8):991-1007. PubMed ID: 16128233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
    Kranz H; Ubrich N; Maincent P; Bodmeier R
    J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin release from poly(D,L-lactide) and poly(lactide-co-glycolide) disks.
    Ozalp Y; Ozdemir N; Hasirci V
    J Microencapsul; 2002; 19(1):83-94. PubMed ID: 11811762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.
    Uchida T; Yagi A; Oda Y; Nakada Y; Goto S
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of poly-hydroxy aliphatic ester polymer type on amoxycillin release from cylindrical compacts.
    Mollo AR; Corrigan OI
    Int J Pharm; 2003 Dec; 268(1-2):71-9. PubMed ID: 14643978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the initial stages of drug release from a degradable matrix of poly(d,l-lactide-co-glycolide).
    Frank A; Kumar Rath S; Boey F; Venkatraman S
    Biomaterials; 2004 Feb; 25(5):813-21. PubMed ID: 14609670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication and characterization of controlled release poly(D,L-lactide-co-glycolide) millirods.
    Qian F; Szymanski A; Gao J
    J Biomed Mater Res; 2001 Jun; 55(4):512-22. PubMed ID: 11288079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring release of ketoprofen enantiomers from biodegradable poly(D,L-lactide-co-glycolide) injectable implants.
    Wang SH; Liang ZH; Zeng S
    Int J Pharm; 2007 Jun; 337(1-2):102-8. PubMed ID: 17296274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method.
    Niwa T; Takeuchi H; Hino T; Kunou N; Kawashima Y
    J Pharm Sci; 1994 May; 83(5):727-32. PubMed ID: 8071830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam.
    Holy CE; Dang SM; Davies JE; Shoichet MS
    Biomaterials; 1999 Jul; 20(13):1177-85. PubMed ID: 10395386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma irradiation effects on molecular weight and in vitro degradation of poly(D,L-lactide-CO-glycolide) microparticles.
    Hausberger AG; Kenley RA; DeLuca PP
    Pharm Res; 1995 Jun; 12(6):851-6. PubMed ID: 7667189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres.
    Hausberger AG; DeLuca PP
    J Pharm Biomed Anal; 1995 May; 13(6):747-60. PubMed ID: 7669829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide).
    Lemoine D; Francois C; Kedzierewicz F; Preat V; Hoffman M; Maincent P
    Biomaterials; 1996 Nov; 17(22):2191-7. PubMed ID: 8922605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of protein diffusion through poly(D,L-lactide-Co-glycolide).
    Fredenberg S; Reslow M; Axelsson A
    Pharm Dev Technol; 2005; 10(2):299-307. PubMed ID: 15926679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of mifepristone from biodegradable matrices: experimental and theoretical evaluations.
    Charlier A; Leclerc B; Couarraze G
    Int J Pharm; 2000 Apr; 200(1):115-20. PubMed ID: 10845692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of poly (lactide-co-glycolide) type and gamma irradiation on the betamethasone acetate release from the in situ forming systems.
    Rafienia M; Emami SH; Mirzadeh H; Mobedi H; Karbasi S
    Curr Drug Deliv; 2009 Apr; 6(2):184-91. PubMed ID: 19450225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro release of theophylline from poly(lactic acid) sustained-release pellets prepared by direct compression.
    Kader A; Jalil R
    Drug Dev Ind Pharm; 1998 Jun; 24(6):527-34. PubMed ID: 9876618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of divalent cations on pore formation and degradation of poly(D,L-lactide-co-glycolide).
    Fredenberg S; Reslow M; Axelsson A
    Pharm Dev Technol; 2007; 12(6):563-72. PubMed ID: 18161629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.